Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis-Reference-Cited by-同舟云学术

Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis

Published:2007-07 Issue:7 Volume:28 Page:334-341
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Amaral Margarida D.,Kunzelmann Karl

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference63 articles.

1. The early stages of the intracellular transport of membrane proteins: clinical and pharmacological implications;Schulein;Rev. Physiol. Biochem. Pharmacol.,2004

2. Pharmacological chaperone action on G-protein-coupled receptors;Bernier;Curr. Opin. Pharmacol.,2004

3. Genetic neurological channelopathies;Hanna;Nat. Clin. Pract. Neurol.,2006

4. Rescue of folding defects in ABC transporters using pharmacological chaperones;Loo;J. Bioenerg. Biomembr.,2005

5. World Health Organization (2004) The Molecular Genetic Epidemiology of Cystic Fibrosis: Report of a Joint Meeting of WHO/ECFTN/ICF(M)A/ECFS, World Health Organization (http://www.cfww.org/WHO_index.asp)

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Future of Cystic Fibrosis Care: Exploring AI's Impact on Detection and Therapy;Current Respiratory Medicine Reviews;2024-11

2. The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health;Progress in Retinal and Eye Research;2024-09

3. Heterocycles fused on a 6,7-coumarin framework: an in-depth review of their structural and pharmacological diversity;Chemical Papers;2024-07-31

4. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del);Cochrane Database of Systematic Reviews;2023-11-20

5. Ocular development after highly effective modulator treatment early in life;Frontiers in Pharmacology;2023-09-19